CS高端制 (930820.csi)A股通融申编制方案单张 | ( 市盈率 50.88 | 市净率 4.03 | 股息率 0.92% )·市值加权 | 发布时间2016-05-11样本数499调样频率半年类型主题热点收盘点位8,732.41点位涨跌幅1.11%成交金额8,045.96亿元市值32.79万亿元A股市值30.26万亿元流通市值27.68万亿元自由流通市值16.58万亿元A股场内基金资产规模1,179.30万元前十大权重21.90%发布以来年化涨跌幅5.88%有数据以来全收益年化涨跌幅6.99%陆股通持仓金额占市值比例3.82% (9,025.45亿元2025-06-30) 融资融券余额占市值比例2.06% (融资余额3,410.62亿元融券余额15.67亿元2025-09-30) | |
| 中证高端制造主题指数选取涉及航天航空与国防、通信设备、半导体产品、生物科技、西药、电子设备与仪器、汽车、电脑与外围设备等领域的上市公司证券作为指数样本，为投资者提供更多样化的投资标的。®基础数据源自中证指数公司。指数估值数据计算说明文档指数财务数据计算说明文档 | |||||
| 备注 (3) | 双击编辑备注 | ||||
CS高端制(930820) - 历史样本权重列表
最后更新于：2025-09-05
| 2025-09-30 前十大权重: 21.90% | 2025-09-29 前十大权重: 22.07% | 2025-09-26 前十大权重: 21.98% | 2025-09-25 前十大权重: 22.26% | 2025-09-24 前十大权重: 22.02% | 2025-09-23 前十大权重: 22.15% | 2025-09-22 前十大权重: 22.06% | 2025-09-19 前十大权重: 21.99% | 2025-09-18 前十大权重: 21.83% | 2025-09-17 前十大权重: 21.87% | 2025-09-16 前十大权重: 21.64% | 2025-09-15 前十大权重: 21.78% | 2025-09-12 前十大权重: 21.58% | 2025-09-11 前十大权重: 21.59% | 2025-09-10 前十大权重: 21.26% | 2025-09-09 前十大权重: 20.99% | 2025-09-08 前十大权重: 21.13% | 2025-09-05 前十大权重: 21.72% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
宁德时代.sz6.08% | 宁德时代.sz6.08% | 宁德时代.sz5.92% | 宁德时代.sz5.99% | 宁德时代.sz5.85% | 宁德时代.sz5.79% | 宁德时代.sz5.81% | 宁德时代.sz5.88% | 宁德时代.sz5.84% | 宁德时代.sz6.00% | 宁德时代.sz5.70% | 宁德时代.sz5.76% | 宁德时代.sz5.31% | 宁德时代.sz5.27% | 宁德时代.sz5.37% | 宁德时代.sz5.47% | 宁德时代.sz5.46% | 宁德时代.sz5.47% |
新易盛.sz2.08% | 新易盛.sz2.23% | 新易盛.sz2.19% | 中际旭创.sz2.23% | 中际旭创.sz2.19% | 中际旭创.sz2.30% | 中际旭创.sz2.21% | 中际旭创.sz2.26% | 中际旭创.sz2.19% | 中际旭创.sz2.17% | 中际旭创.sz2.23% | 中际旭创.sz2.23% | 中际旭创.sz2.32% | 中际旭创.sz2.42% | 中际旭创.sz2.20% | 中际旭创.sz2.07% | 中际旭创.sz2.09% | 中际旭创.sz2.31% |
中际旭创.sz2.05% | 中际旭创.sz2.14% | 中际旭创.sz2.17% | 新易盛.sz2.15% | 立讯精密.sz2.08% | 新易盛.sz2.09% | 新易盛.sz2.02% | 新易盛.sz2.10% | 新易盛.sz2.06% | 新易盛.sz2.08% | 新易盛.sz2.09% | 新易盛.sz2.14% | 新易盛.sz2.20% | 新易盛.sz2.33% | 新易盛.sz2.14% | 恒瑞医药.sh2.05% | 恒瑞医药.sh2.05% | 新易盛.sz2.21% |
立讯精密.sz1.88% | 立讯精密.sz1.90% | 立讯精密.sz1.92% | 立讯精密.sz2.01% | 新易盛.sz2.05% | 立讯精密.sz1.98% | 恒瑞医药.sh1.89% | 恒瑞医药.sh1.88% | 恒瑞医药.sh1.91% | 恒瑞医药.sh1.89% | 恒瑞医药.sh1.89% | 恒瑞医药.sh1.90% | 寒武纪.sh1.92% | 恒瑞医药.sh1.89% | 恒瑞医药.sh2.02% | 新易盛.sz2.02% | 新易盛.sz1.98% | 恒瑞医药.sh2.06% |
恒瑞医药.sh1.83% | 恒瑞医药.sh1.79% | 恒瑞医药.sh1.84% | 恒瑞医药.sh1.86% | 恒瑞医药.sh1.82% | 恒瑞医药.sh1.85% | 立讯精密.sz1.84% | 比亚迪.sz1.79% | 比亚迪.sz1.80% | 比亚迪.sz1.82% | 寒武纪.sh1.84% | 寒武纪.sh1.85% | 恒瑞医药.sh1.91% | 比亚迪.sz1.79% | 比亚迪.sz1.84% | 比亚迪.sz1.85% | 比亚迪.sz1.83% | 比亚迪.sz1.86% |
比亚迪.sz1.70% | 比亚迪.sz1.71% | 比亚迪.sz1.72% | 比亚迪.sz1.69% | 比亚迪.sz1.67% | 比亚迪.sz1.71% | 比亚迪.sz1.74% | 寒武纪.sh1.70% | 寒武纪.sh1.79% | 寒武纪.sh1.81% | 比亚迪.sz1.79% | 比亚迪.sz1.82% | 比亚迪.sz1.78% | 寒武纪.sh1.79% | 药明康德.sh1.72% | 药明康德.sh1.72% | 药明康德.sh1.76% | 药明康德.sh1.71% |
药明康德.sh1.60% | 寒武纪.sh1.60% | 寒武纪.sh1.65% | 寒武纪.sh1.67% | 寒武纪.sh1.67% | 寒武纪.sh1.68% | 寒武纪.sh1.74% | 立讯精密.sz1.70% | 立讯精密.sz1.62% | 药明康德.sh1.65% | 药明康德.sh1.63% | 药明康德.sh1.65% | 立讯精密.sz1.65% | 立讯精密.sz1.66% | 寒武纪.sh1.71% | 寒武纪.sh1.66% | 寒武纪.sh1.61% | 寒武纪.sh1.70% |
中芯国际.sh1.60% | 中芯国际.sh1.57% | 中芯国际.sh1.55% | 工业富联.sh1.57% | 工业富联.sh1.59% | 工业富联.sh1.68% | 工业富联.sh1.67% | 药明康德.sh1.64% | 药明康德.sh1.62% | 立讯精密.sz1.59% | 立讯精密.sz1.62% | 立讯精密.sz1.65% | 药明康德.sh1.63% | 药明康德.sh1.62% | 立讯精密.sz1.57% | 立讯精密.sz1.57% | 立讯精密.sz1.60% | 立讯精密.sz1.53% |
寒武纪.sh1.58% | 工业富联.sh1.53% | 工业富联.sh1.52% | 药明康德.sh1.55% | 中芯国际.sh1.56% | 药明康德.sh1.56% | 药明康德.sh1.62% | 工业富联.sh1.59% | 工业富联.sh1.54% | 工业富联.sh1.46% | 工业富联.sh1.45% | 工业富联.sh1.46% | 工业富联.sh1.52% | 工业富联.sh1.45% | 工业富联.sh1.37% | 中芯国际.sh1.32% | 中芯国际.sh1.45% | 中芯国际.sh1.45% |
工业富联.sh1.50% | 药明康德.sh1.52% | 药明康德.sh1.52% | 中芯国际.sh1.54% | 药明康德.sh1.53% | 中芯国际.sh1.52% | 中芯国际.sh1.52% | 中芯国际.sh1.46% | 中芯国际.sh1.46% | 中芯国际.sh1.41% | 海光信息.sh1.40% | 中芯国际.sh1.33% | 中芯国际.sh1.33% | 中芯国际.sh1.36% | 中芯国际.sh1.33% | 工业富联.sh1.25% | 工业富联.sh1.30% | 工业富联.sh1.41% |
